We have a mouse model for Alzheimer's disease which is expressing human amyloid beta in plaques. We want to detect those using a mouse anti-amyloid beta antibody, using a fluorescently labeled secondary antibody, but this gives us quite a lot of background. Especially in the blood vessels, where the secondary antibody is binding endogenous IgG molecules. I have thought of two possible strategies to overcome this, and I would like to ask you if you could help me choose the best strategy.
What I've tried so far:
Mouse anti-amyloid beta as primary antibody, donkey anti-mouse Alexa Fluor Plus 647 as secondary antibody.
What I could try:
1: the anti-amyloid beta antibody is a specific subtype: IgG2b, kappa. I can try a specific anti-mouse IgG2b secondary antibody, like this one: Goat anti-Mouse IgG2b Cross-Adsorbed, Alexa Fluor 647 (A-21242) (thermofisher.com). This should reduce the amount of background staining.
2: a mouse-on-mouse kit that blocks endogenous IgG molecules before incubation with the antibodies, like this one: Mouse on Mouse (M.O.M.) Detection Kit, Basic (vectorlabs.com), in combination with Alexa Fluor 647-conjugated streptavidin.
The second option should, in theory, give better results. But it is more expensive because I have to buy two things.